SPOTLIGHT: Wyeth sues Watson to quash generic


It's Watson Pharmaceuticals and Wyeth in the ring, as Watson filed for FDA approval to sell a generic version of Lybrel, a birth control pill, and Wyeth responded by suing for patent infringement. Report, Report

Suggested Articles

Pfizer has scored FDA approval for its Humira biosimilar, but it can't launch the product for several years under a patent settlement.

The 3-2 vote on the deal was split along the party lines, spelling trouble for future biopharma M&A deals should Democrats move into the White House.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.